A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance
Authors (first, second and last of 4)
Collection
Cannabinoids in Neurology and Psychiatry
A collection of recent articles discussing the potential of cannabinoids in the treatment of neurological and psychiatric disorders
Articles (18 in this collection)
-
-
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
Authors (first, second and last of 4)
-
Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study
Authors (first, second and last of 7)
-
Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome
Authors (first, second and last of 7)
-
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis
Authors (first, second and last of 8)
-
-
A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug–Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy
Authors (first, second and last of 10)
-
Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
Authors (first, second and last of 7)
-
Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety Disorder
Authors (first, second and last of 6)
-
-
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
Authors (first, second and last of 13)
-
Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
Authors (first, second and last of 6)
-
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Authors (first, second and last of 5)
-
A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms
Authors (first, second and last of 4)
-
Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis
Authors (first, second and last of 5)
-
Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System
Authors (first, second and last of 7)
-
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
Authors (first, second and last of 7)
-
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer’s Disease
Authors (first, second and last of 9)
